Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
10/2005
10/04/2005US6951865 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same
10/04/2005US6951863 Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
10/04/2005US6951850 Dipeptide derivatives
10/04/2005US6951848 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
10/04/2005CA2245539C Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
09/2005
09/29/2005WO2005090358A2 7h-8,9-dihydro-pyrano (2,3-c) imidazo (1,2a) pyridine derivatives and their use as gastric acid secretion inhibitors
09/29/2005WO2005090357A1 Tricyclic benzopyran compound as anti-arrhythmic agents
09/29/2005WO2005090356A1 1,3 DIHYDROFURO [3,4-c]PYRIDINES AND THEIR PREPARATION
09/29/2005WO2005090341A1 Azabicyclooctan-3-one derivatives and use thereof
09/29/2005WO2005090337A1 Opioid receptor antagonists
09/29/2005WO2005090327A1 Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles
09/29/2005WO2005089294A2 Synthesis of indenoisoquinoliniums and methods of use
09/29/2005WO2005070940A3 Rifamycin derivatives effective against drug-resistant microbes
09/29/2005WO2005067900A3 Azabenzofuran substituted thioureas as inhibitors of viral replication
09/29/2005WO2005062991A3 Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers
09/29/2005WO2005054234A3 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
09/29/2005WO2005054183A3 Quinolinone based protein kinase inhibitors
09/29/2005WO2005025507A3 Dihydropyridine compounds for treating or preventing metabolic disorders
09/29/2005WO2005009398A3 Tetracyclic benzamide derivatives and methods of use thereof
09/29/2005WO2003099822A3 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/29/2005US20050215612 Anticancer agents; such as succinic acid mono-[5-(1-benzyl-1H-indazol-3-yl)-furan-2-ylmethyl]ester, sodium salt; inhibit cancer cell growth
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215574 4-anilino quinazoline derivatives as antiproliferative agents
09/29/2005US20050214807 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection
09/29/2005DE102004013227A1 Production of 3-beta-aminonortropane derivatives, useful as e.g. N-methyl-D-aspartate receptor modulators, or synthetic intermediates, comprises preparing an imine, converting the imine into a stable tautomer or isomer, and hydrolyzing
09/29/2005DE102004001873A1 Cyanopyrimidinone Cyanopyrimidinone
09/29/2005CA2559310A1 7h-8,9-dihydro-pyrano (2,3-c) imidazo (1,2a) pyridine derivatives and their use as gastric acid secretion inhibitors
09/29/2005CA2558652A1 Opioid receptor antagonists
09/28/2005EP1580216A1 High-molecular weight derivatives of camptothecins
09/28/2005EP1578743A2 Antibacterial agents
09/28/2005EP1578741A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/28/2005EP1578456A1 Isotope labeled camptothecin derivatives
09/28/2005EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
09/28/2005EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
09/28/2005CN1675219A Novel anticancer conjugates of camptothecin and unsaturated fatty acids
09/28/2005CN1675218A Novel tricyclic spiropiperidines or spiropyrrolidines
09/28/2005CN1675210A Substituted 2, 4-dihydro-pyrrolo[3, 4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
09/28/2005CN1675208A Novel fused imidazole derivative
09/28/2005CN1673226A Carboxylate medicine precursors of hydroxycamptothecine and its derivative and thei prepn and application
09/28/2005CN1673225A Carbonate medicine precursors of hydroxycamptothecine and its derivative and their prepn and application
09/28/2005CN1220692C Process for preparing cephalotaxane derivatives
09/27/2005US6949647 Economically synthesis using narciclasine; epoxidation and reduction to diol; forming cyclic sulfate, ring opening with cesium benzoate and saponification
09/22/2005WO2005087778A1 Tricyclic furopyridine derivatives useful in the treatment of hyper-proliferative disorders
09/22/2005WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient
09/22/2005WO2005087753A1 Reagent for reaction
09/22/2005WO2005087731A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087232A1 Bicyclic modulators of androgen receptor function
09/22/2005WO2005087227A1 Arylalkylamino-substituted quinazoline analogues
09/22/2005WO2005087225A1 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents
09/22/2005WO2005056524A3 Therapeutic agents useful for treating pain
09/22/2005US20050209463 Novel compound having antitumor activity and process for producing the same
09/22/2005US20050209296 1,2-Diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209284 Tec kinase inhibitors
09/22/2005US20050209273 Neuroprotectants, analgesics or anticonvulsants
09/22/2005US20050209263 7-Substituted camptothecin and camptothecin analogs and methods for producing the same
09/22/2005US20050209253 Corticotropin releasing factor (CRF) receptor antagonists; nervous system disorders, ischemia, gastrointestinal disorders, hypertension, eating disorders, sleep disorders; e.g. 2-(1-[7-(2,6-dibromo-4-trifluoromethyl-phenyl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-piperidin-2-yl)-ethanol
09/22/2005US20050209233 Neuropeptide Y5 (NPY-5) receptor antagonists or agonists; eating disorders, diabetes dyslipidemia, hypertension, and sleep disorders; pyridazin-3-ylamino-substituted dibenzothiophenes and S-oxides thereof
09/22/2005US20050209210 Having activity against both rifampin and ciprofloxacin-resistant microorganisms
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005US20050209191 1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209174 Especially conjugating derivatives of paclitaxel, cholesterol, camptothecin, and rhodamine123 to transferrins, side effect reduction
09/22/2005US20050209164 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
09/22/2005US20050208588 Supports for oligomer synthesis
09/22/2005CA2557495A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005CA2555867A1 Arylalkylamino-substituted quinazoline analogues
09/21/2005EP1575947A1 2-oxopyridin-3-yl thia(di)azole derivatives for use in the treatment of cell proliferation and apoptosis related diseases
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005CN1671712A 1, 2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/21/2005CN1671711A Calcitonin gene related peptide receptor antagonists
09/21/2005CN1671684A Novel benzodioxoles
09/21/2005CN1219511C Method for curing sepsis
09/20/2005US6946473 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085234A2 Bycyclic anthranilamide derivatives useful as insecticides
09/15/2005WO2005085228A1 Cycloalkanopyridine derivative
09/15/2005WO2005085214A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005WO2005085197A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
09/15/2005WO2005084315A2 Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
09/15/2005WO2005065050A3 Bicyclic compound
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005039484A3 Indolocarbazole anticancer agents and methods of using same
09/15/2005US20050203162 Cytotoxic agents and methods of use
09/15/2005US20050203146 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
09/15/2005US20050203119 Dihydropyridine compounds for treating or preventing metabolic disorders
09/15/2005US20050203118 Rheumatic diseases; antiarthritic agents; multiple sclerosis; antidiabetic agents; asthma therapy; skin disorders
09/15/2005US20050203076 E.g., 11-Dideoxy-4,11-dihydroxyiminorifamycin S and (R/S)-3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-2-methyl-piperazin-1-yl-aminomethylenyl]-11-deoxy-11-hydroxyiminorifamycin SV; especially effective against rifamycin-resistant microbes
09/15/2005US20050202974 Ketol fatty acid derivatives and plant growth regulators
09/15/2005CA2558278A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005CA2558274A1 Cycloalkanopyridine derivative
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005CA2557301A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
09/15/2005CA2557160A1 Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
09/15/2005CA2556387A1 Bicyclic anthranilamide derivatives useful as insecticides
09/15/2005CA2549705A1 Switchable window based on electrochromic polymers
09/14/2005EP1574508A1 Process for the preparation of acetals and ketals of 3-amimo-5-(hydroxymethyl)-cyclopentane-1,2-diols and their derivatives and salts
09/14/2005EP1572696A1 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones
09/14/2005EP1572662A1 Pyrazole and imidazole compounds and uses thereof
09/14/2005EP1572659A2 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence
09/14/2005EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
09/14/2005EP1572215A1 Benzo[d]azepine derivatives for the treatment of neurological disorders
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 298